Home > Insider Trading > Filing (0000919574-21-000552)

Filing Details

Accession Number:: 0000919574-21-000552
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-28 17:48:43
Reporting Period:: 2021-01-26

Accepted Time:: 2021-01-28 17:48:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
718937	Staar Surgical Co	STAA	Ophthalmic Goods (3851)	953797439

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1278386	Broadwood Partners, L.p.	C/O Broadwood Capital Inc. 142 West 57Th Street, 11Th Floor New York NY 10019	No	No	Yes	No
1278387	Broadwood Capital Inc	142 West 57Th Street, 11Th Floor New York NY 10019	No	No	Yes	No
1278388	C Neal Bradsher	C/O Broadwood Capital Inc. 142 West 57Th Street, 11Th Floor New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-01-26	347,000	$102.33	10,342,905	No	4	S	Direct
Common Stock	Disposition	2021-01-26	0	$0.00	10,342,905	No	4	S	Indirect	Footnote
Common Stock	Disposition	2021-01-27	164,686	$103.99	10,178,219	No	4	S	Direct
Common Stock	Disposition	2021-01-27	0	$0.00	10,178,219	No	4	S	Indirect	Footnote
Common Stock	Disposition	2021-01-28	278,197	$105.83	9,900,022	No	4	S	Direct
Common Stock	Disposition	2021-01-28	0	$0.00	9,900,022	No	4	S	Indirect	Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	Footnote
No	4	S	Direct
No	4	S	Indirect	Footnote
No	4	S	Direct
No	4	S	Indirect	Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,900	Direct

Footnotes

The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
This constitutes the weighted average sale price. The prices range from $96.50 to $105.30. Full information regarding the number of shares sold at each separate price are set forth on Exhibit B to the Schedule 13D/A filed by the Reporting Persons with the Securities and Exchange Commission (the "SEC") on the date hereof, which is incorporated herein by reference.
This constitutes the weighted average sale price. The prices range from $100.05 to $106.58. Full information regarding the number of shares sold at each separate price are set forth on Exhibit B to the Schedule 13D/A filed by the Reporting Persons with the SEC on the date hereof, which is incorporated herein by reference.
This constitutes the weighted average sale price. The prices range from $100.43 to $108.81. Full information regarding the number of shares sold at each separate price are set forth on Exhibit B to the Schedule 13D/A filed by the Reporting Persons with the SEC on the date hereof, which is incorporated herein by reference.
These securities are directly owned by Neal C. Bradsher.